Skip to main content
. Author manuscript; available in PMC: 2015 Jan 1.
Published in final edited form as: Genet Med. 2013 Dec 19;16(7):529–534. doi: 10.1038/gim.2013.187

Table 1.

Case/control study number consists of 50% cancer cases and 50% cancer free controls. Assuming cumulative incidence of breast cancer of 0.08 for individuals in study, α= 0.1, β = 0.2, MAF = minor allele frequency

Subjects necessary to characterize as pathogenic
RR Tumor Type MAF = 0.001 MAF = 0.0001 MAF = 0.00001
RR = 12 Breast 663 6,544 65,358
RR = 6 Breast 1,652 16,392 163,792
RR = 3 Breast 5,491 54,650 546,238
RR = 1.5 Breast 49,162 490,135 4,899,864